SSP Co., Ltd. is a pharmaceutical company specializing in OTC (over-the-counter) drugs and healthcare products, providing a variety of products to meet health needs for more than 250 years since its establishment in 1765. In 2017, the company became
1765 | Founded as Minoya Yakubo in Yaesu, Tokyo by Shosuke Shirai |
1940 | Company name changed to SSP Co., Ltd. |
1964 | Narita Site opened in Narita-city, Chiba prefecture |
1985 | First to market ibuprofen as “EVE” OTC drug in Japan |
2003 | First to market sleep-improving drug as “Drewell" OTC drug in Japan |
2011 | First to market epinastine hydrochloride as “Alesion” OTC drug in Japan |
2017 | Joined the Sanofi Group as a result of the business exchange between Boehringer Ingelheim and Sanofi. |